One-off low-dose CT lung cancer screening in China: an appropriate strategy?

Harry de Koning

doi:10.1016/S2213-2600(22)00047-9

One-off low-dose CT lung cancer screening in China: an appropriate strategy?

Public Health

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	320-322
Number of pages	3
Journal	The Lancet Respiratory Medicine
Volume	10
Issue number	4
DOIs	https://doi.org/10.1016/S2213-2600(22)00047-9
Publication status	Published - Apr 2022

Bibliographical note

I am the recipient of grants from EU Horizon 2020 (4-IN-THE-LUNG-RUN; grant number 848294) and the Dutch Cancer Society (CLEARLY-TRANSCAN-FP-045). I have received fees for lung symposia organised by Merck Sharp & Dohme, Teva, Menarini, and AstraZeneca, and fees as a reviewer for Ipsos MORI, Targeted Lung Health Checks programme, England.

© 2022 Elsevier Ltd. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2213-2600(22)00047-9

Cite this

@article{a6d2aa2c4e474d1cb90e378cb2f9dc57,

title = "One-off low-dose CT lung cancer screening in China: an appropriate strategy?",

author = "{de Koning}, Harry",

note = "I am the recipient of grants from EU Horizon 2020 (4-IN-THE-LUNG-RUN; grant number 848294) and the Dutch Cancer Society (CLEARLY-TRANSCAN-FP-045). I have received fees for lung symposia organised by Merck Sharp & Dohme, Teva, Menarini, and AstraZeneca, and fees as a reviewer for Ipsos MORI, Targeted Lung Health Checks programme, England. {\textcopyright} 2022 Elsevier Ltd. All rights reserved.",

year = "2022",

month = apr,

doi = "10.1016/S2213-2600(22)00047-9",

language = "English",

volume = "10",

pages = "320--322",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Ltd.",

number = "4",

}

TY - JOUR

T1 - One-off low-dose CT lung cancer screening in China

T2 - an appropriate strategy?

AU - de Koning, Harry

N1 - I am the recipient of grants from EU Horizon 2020 (4-IN-THE-LUNG-RUN; grant number 848294) and the Dutch Cancer Society (CLEARLY-TRANSCAN-FP-045). I have received fees for lung symposia organised by Merck Sharp & Dohme, Teva, Menarini, and AstraZeneca, and fees as a reviewer for Ipsos MORI, Targeted Lung Health Checks programme, England. © 2022 Elsevier Ltd. All rights reserved.

PY - 2022/4

Y1 - 2022/4

UR - http://www.scopus.com/inward/record.url?scp=85127174944&partnerID=8YFLogxK

U2 - 10.1016/S2213-2600(22)00047-9

DO - 10.1016/S2213-2600(22)00047-9

M3 - Comment/Letter to the editor

SN - 2213-2600

VL - 10

SP - 320

EP - 322

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 4

ER -

One-off low-dose CT lung cancer screening in China: an appropriate strategy?

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this